M icrosurgery for unruptured intracranial aneurysms (UIAs) should be performed carefully, as patients with UIAs are usually asymptomatic or have minimal neurological deficits. Previous studies have reported that overall morbidity rates of surgery for UIAs range between 2.2% and 13.7%, 1, 3, 18, 36, 47, 67 with ischemic complications being a major cause of morbidity. 5, 9, 36, 41, 54, 59 Thus, preventing ischemic complications during UIA surgery should reduce the morbidity rate.
chemic complications during aneurysm surgery, including intraoperative CT, MRI, digital subtraction angiography (DSA), microvascular Doppler (MVD) sonography, indocyanine green (ICG) videoangiography, and neurophysiological monitoring.
2 Among these methods, intraoperative neurophysiological monitoring, including monitoring of somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs), has become more common and is often considered a predictor of neurological functional outcomes. 12, [20] [21] [22] 29, 37, 39, 44, 58, 60, 63, 69 Previous MEP/SEP studies were primarily focused on sensitivity and specificity, which represents their efficacy in monitoring. However, when using intraoperative evoked potential (EP) monitoring, surgeons often encounter both false-positive cases and false-negative cases. Unfortunately, the incidence and potential causes of these events are not well established. Therefore, the purpose of this study was to evaluate the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and incidences of falsepositive and false-negative results in patients who underwent surgery for UIAs. Furthermore, possible factors for false-positive and false-negative results during intraoperative transcranial EP monitoring are discussed.
Methods
This retrospective study was approved by the institutional review board of Asan Medical Center.
All cases in which patients with UIAs underwent microsurgical treatment involving aneurysm clipping with intraoperative EP monitoring between January 2012 and April 2016 were reviewed. Patients with any additional intracranial pathology or with neurological deficits were excluded from the study to minimize confounding effects on monitoring. Each patient's medical records included patient characteristics, aneurysm location, anesthetic regimen, surgical method, any neurological deficits, any perioperative complications, clinical outcomes, medical history, baseline and intraoperative EP results, and radiological images. All surgeries were performed by 2 experienced neurosurgeons. UIAs were microsurgically treated with aneurysm neck clipping with additional trapping with or without bypass surgery if needed, according to interdisciplinary consensus. A temporary clip was applied to the parent artery for up to 3 minutes when proximal blood flow control was needed during surgery, with at least a 5-minute interval between episodes of temporary clipping. The temporary clip was removed as soon as possible whenever there was a significant EP change. Immediate postoperative neurological examinations included mental status assessment, a motor function test, and a basic cranial nerve function test performed by the neurosurgeons when the patient arrived in the intensive care unit. Immediate postoperative brain CT, CT angiography, and perfusion CT were performed with a CereTom mobile CT scanner (Neurologica) before extubation in the operation room, or a conventional CT scan with CT angiography was performed as soon as possible after extubation. Routine follow-up brain CT was performed 3 days postoperatively. A brain MRI (with or without diffusion-weighted sequences) or DSA was performed if the patient presented with neurological deficits or if there might have been a violation of the parent artery during the surgery. Patients' functional status was assessed with the Glasgow Outcome Scale 28 at discharge and with the modified Rankin Scale (mRS) 55 6 months postoperatively for the evaluation of clinical outcomes.
Anesthesia Regimen
Total intravenous anesthesia was used in all cases, and the standard American Society of Anesthesiologists guidelines were followed. Anesthesia was induced with propofol (1.5-2.5 mg/kg), followed by total intravenous anesthesia using a commercially available 2-channel target-controlled infusion pump (Orchestra; Fresenius Vial). Anesthesia was maintained using continuous infusion of propofol (2.5 mg/ml) and remifentanil (7-9 ng/ml) before opening the dura, and the infusions were increased to 3.0 mg/ml and 15 ng/ml, respectively, after opening the dura. The depth of anesthesia was monitored using a Bispectral Index (BIS system; Covidien; range [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] .
During the study period, there was a protocol shift involving the use of neuromuscular blockades (NMBs; rocuronium or vecuronium) during surgery with EP monitoring. The tendency to use NMBs gradually decreased during the study period. Therefore, we categorized patients into 2 groups: those given a continuous low-dose NMB throughout surgery (cNMD group) and those who received a single NMB bolus injection during the intubation process for anesthesia (sNMB group).
EP Monitoring
In all cases, preoperative SEP evaluation was performed the day before surgery with a Neuropack MEB-2200 (Nihon Kohden). From this evaluation, the baseline SEP and any abnormal amplitude or latency that existed preoperatively could be determined. These EP results constituted the baseline reference and were used during intraoperative monitoring. Preoperative MEP evaluation was not considered because of the pain caused by electrical stimulation during the evaluation. The same device was used for intraoperative EP monitoring, which was performed by trained neurophysiologists. All electrodes were placed bilaterally, allowing the EP results of the ipsilateral side to be used as a reference to reduce the chance of alterations due to surgical procedures. Subcutaneous, bilateral placement of cranial electrodes at C3/C4 was performed for both MEP and SEP monitoring according to the International 10-20 system.
For MEP monitoring, a train of 6 constant-current anodal 0.5-msec-wide stimuli delivered at 3-msec interstimulus intervals was used to obtain MEP waves. Bilateral MEPs were recorded using patch electrodes at the tibialis anterior, adductor hallucis, and abductor pollicis brevis muscles based on the aneurysm location. MEPs were recorded within a 150-msec interval with filtration and amplification (bandpass 30-2000 Hz, 10,000 times).
The baseline stimulus intensity was tested a minimum of 3 times before the intradural procedure (before scalp incision, craniotomy, and dura incision), and a minimal stimulus intensity was used until EP responses were detectable in the lower extremities. Once the baseline intensity was established, the baseline amplitudes of MEP/SEP waves were chosen and documented in the neurophysiology event log. SEP results from the bilateral median and tibial nerves were monitored throughout the surgery based on the location of the aneurysm. SEP results were detected from the cranial electrode following continuous stimulation with a 4.7-Hz current at minimal stimulus intensity.
Various methods of defining alert criteria have been discussed in previous studies, with the majority of authors suggesting that a decrease in amplitude of greater than 50% be considered the clinical warning sign. 13, 22, 25, 26, 37, 57, 63, 64, 69 Thus, we applied this criterion, and when any such reduction occurred, the neurophysiology team immediately shared the EP results with the surgeon. MEP stimulation was routinely performed after clipping. Additional stimulation was performed upon SEP decline, at the surgeon's request, and at skull closure. The final EP monitoring was performed during scalp closure, using MEPs. If there was change in the EP results, the stimulation intensity was gradually increased and checked repeatedly. The stimulation intensity was kept below 300 V to avoid false-negative results.
As mentioned above, if an EP change met the alert criterion, the neurophysiologist immediately warned the surgeon. We usually follow several steps to find the cause of EP change. First, we stop the procedure and search for the possible cause of ischemia by careful inspection. Second, MVD sonography is performed to verify the blood flow around the parent artery and surrounding perforators. Cortical artery blood flow is also checked to identify any subtle decrease in blood flow. This procedure is usually performed within 1 minute of the EP change. If there is a notable decrease in blood flow, release of the temporary or permanent clip usually leads to recovery of EP results. If the EP results do not recover, we replace the CSF lost with normal saline and tilt the patient's head toward the neutral position. Placing saline-soaked cotton into the subdural space can also be helpful. Additional ICG videoangiography could be considered for confirming patency in this situation. Despite these methods, EP changes could still meet the alert criterion; at this point, the surgeon must decide whether to proceed with the surgery.
Definition of False Negative and False Positive
Evoked potential monitoring is a neurophysiological measurement of corticospinal tract (MEPs) and spinothalamic tract (SEPs) function. To identify false-negative and false-positive results, the proper neurological examination should be a motor function test for MEPs and a sensory function test for SEPs. 24 However, there is a limitation of evaluation of sensory function in immediate postoperative circumstances. Thus, positive findings in terms of functional outcome were defined as any grade of motor weakness or asymmetry in the immediate postoperative motor function test. Because this definition is based on normal motor function, false-negative cases were defined as patients who had no significant EP change during the surgery but had localized motor weakness or asymmetry in their immediate postoperative motor function test due to a newly developed brain lesion identified from brain CT or MRI. Significant MEP or SEP events were categorized as persistent EP changes until final stimulation (analyzed as persistent MEP changes or persistent SEP changes) or any form-episodic or persistent-of EP change (analyzed as any MEP change or any SEP change).
Unlike false-negative cases, defining false-positive cases is relatively complicated. Intraoperative EP changes are considered a surrogate indicator for ischemic injury, although significant EP changes are not always associated with brain infarction or motor weakness. 21 Moreover, brain infarctions may be asymptomatic. Without tractography data, it is often hard to determine whether a brain infarction involves the corticospinal tract. Additionally, interpretation of a recovered EP change may suggest some potential recovery of motor functions. Thus, we defined false-positive cases as those in which patients had a persistent significant EP change until the completion of EP monitoring but did not develop any postoperative motor weakness or new ischemic brain lesions.
Statistical Analysis
Sensitivity, specificity, PPV, and NPV were calculated with a Blaker exact 95% confidence interval using the "PropCIs" package in R software version 3.1.0 for Windows (R Foundation for Statistical Computing). 16 A Pearson test, Spearman-rho test, and univariate and multivariate logistic regression analyses were used for risk factor analysis for false-positive and false-negative cases using commercial software (IBM SPSS Statistics, version 22; IBM Corp.).
Results
From January 2012 to April 2016, 1571 patients without neurological deficits underwent surgical treatment of a total of 1902 UIAs. Fifty-seven patients who underwent UIA surgery (1 UIA each) without EP monitoring were excluded. Therefore, data from 1514 patients who underwent treatment of 1845 UIAs were analyzed in this study. Patient demographic data and aneurysm characteristics are presented in Table 1 . The majority of the aneurysms were treated by aneurysm neck clipping (1843 aneurysms in 1512 patients); there was 1 case each of clipping with bypass and trapping (which included clipping) with bypass. There were 1392 patients in the cNMB group and 122 patients in the sNMB group. No statistically significant difference was found between the 2 groups with respect to patient characteristics, aneurysm location, operating method, complication rates, functional outcome, radiological outcome, or the rate of false positives or false negatives.
There were 6 patients with a Glasgow Outcome Scale (GOS) score of 4 (moderate disability) at discharge (0.40%). Evaluation of mRS scores obtained 6 months postoperatively showed that 1 patient (0.07%) had a score of 3, 2 patients (0.13%) had a score of 2, and 7 patients (0.46%) had a score of 1, while the remaining patients had a score of 0 (no symptoms). Overall, complications were identified in 75 patients (4.95%), with 36 patients (2.38%) having morbidity at their 6-month follow-up evaluation. A summary of complications is presented in Table 2 . The leading cause of complications was a newly developed infarction found on brain CT or MRI within 3 days of surgery and confirmed by an experienced radiologist; this occurred in 72 cases, with the patients showing symptoms in 18 (25%) of these cases and being asymptomatic in the remaining 54 cases (75%). Symptoms of the infarctions were motor weakness (in 10 cases), confusion or delirium (in 5 cases), aphasia or dysphasia (in 2 cases), and syndrome of inappropriate antidiuretic hormone secretion (in 1 case). In an additional 4 cases, the patients had brain hemorrhage, and in another case the patient had perfusion delay ( Table 2) .
The most important symptom correlating with an abnormal MEP result was motor weakness. A total of 15 patients showed motor weakness; in 10 of these patients, it was detected on the immediate postoperative motor function test, and in the remaining 5 it was observed several hours after the immediate postoperative motor function test. Causes for the immediate motor weakness were infarction (8 cases) and intracerebral hemorrhage (ICH) with subarachnoid hemorrhage (SAH) (1 case). One of the 8 patients with infarction had a persistent significant EP change, which was a true positive (i.e., this case did not fit the criteria for false positive or false negative). The remaining patient with immediate postoperative motor weakness had decreased blood flow on perfusion CT without having demonstrated any EP change during surgery. DSA was immediately performed and revealed parent artery stenosis due to aneurysm neck clipping. Repeat surgery was performed for clip repositioning after the DSA, and the patient did not have a brain infarction. This patient was excluded from the false-negative cases, as there was no newly developed brain lesion on postoperative imaging.
None of the 5 patients with delayed motor weakness had any EP change during surgery. Delayed motor weakness was caused by postoperative hematomas, such as epidural or subdural hemorrhages. In the remaining 2 cases, it was caused by brain infarction, which occurred 4 and 9 days postoperatively, respectively. Neither of these patients exhibited any motor weaknesses during their immediate postoperative neurological function tests. However, they both had an acute infarction in a clip-related territory. One had an acute infarction in the right anterior choroidal artery (AChA) territory during clipping of a posterior communicating artery aneurysm, and the other had an acute infarction in the right frontal region from the right A 2 -A 3 junction aneurysm clipping. We presumed that brain expansion and restoration of CSF led to aneurysm clip torsion or rotation, leading to compromised blood flow of the adjacent arteries. The current study had a total of 15 cases with falsepositive findings and 8 with false-negative findings. In all cases with false-positive findings, there were persistent MEP changes, but none of the patients showed motor weakness postoperatively. In contrast, the patients in the 8 cases with false-negative findings showed motor weakness upon immediate postoperative neurological examination. However, they did not have any specific EP changes during the surgery. The incidence of false-positive findings was 0.99%, and that for false-negative findings was 0.53% (Tables 3 and 4) .
Because persistent EP change and an episodic EP change event have the potential to raise different clinical issues, we calculated the sensitivity, specificity, PPV, and NPV for persistent MEP changes, persistent SEP changes, any MEP change, any SEP change, and overall EP changes to compare the differences. All analyses showed high specificity (0.941-0.995) and NPVs (0.993-0.994), with low sensitivity (0.000-0.100) and PPVs (0.000-0.011) ( Table  5) . A subanalysis was also conducted to determine whether any group benefited more from EP monitoring based on sex, age, size of aneurysm, aneurysm location, and multiplicity of aneurysms. However, because of the low incidence of false-positive and false-negative cases, there were no statistically significant findings.
Three illustrative cases are presented in Figs. 1-3 .
Discussion
Complications from microsurgical treatment of UIAs include ischemic brain injury, hemorrhage, hydrocephalus, and seizure. 1, 3, 4, 6, 7, 18, 27, 31, 32, 35, 36, 40, 47, 67 Ischemic brain injury is one of the most common complications of UIA surgery and is reported to occur in 13.2% of surgically treated patients with UIAs. The cause of ischemic brain injury is associated with surgical maneuvers, physiological conditions, anesthesia, and postsurgical complications. 15, 34, 39, 45, 48, 52, 66 Surgical maneuvers that may violate cerebral blood flow and are susceptible to control include clipping the aneurysm neck, prolonged temporary clipping of the parent artery, retraction with a spatula, or causing direct injury to a perforating artery. 39, 46, 50, 51, 56 To avoid ischemia due to surgical events, various intraoperative monitoring methods have been employed, including intraoperative CT, MRI, DSA, MVD sonography, ICG videoangiography, and neurophysiological monitoring.
2
Among these methods, measurement of MEPs and SEPs has the advantage of being relatively less invasive and less expensive; moreover, MEPs and SEPs can be measured throughout the surgery with continuous or intermittent monitoring. EP monitoring can also detect both superficial and deep ischemic brain lesions.
2 However, there is also a chance of complications associated with EP monitoring; patients may experience seizure, tongue and lip lacerations, mandibular fracture, cardiac arrhythmia, and intraoperative awareness. 10, 11, 33, 53 Our institute used intraoperative MVD sonography and ICG videoangiography before adding the use of intraoperative EP monitoring, and recently we adopted the mobile CT scan. Each intraoperative monitoring method has a different spectrum of detection, continuity, monitored features, and invasiveness. Therefore, the use of multiple monitoring techniques provides greater coverage and detection of surgically induced complications, leading to safer surgical treatment of UIAs. 42, 43 In transcranial EP monitoring, meticulous interpretation of each event is crucial. Thus, a baseline MEP/SEP recording is performed the day before surgery to provide information on the preoperative elec- trophysiological status. These results can be used to avoid false positives when abnormal EP results are discussed intraoperatively. Additionally, MVD sonography and ICG videoangiography can aid in determining whether to continue the surgical process in such cases. Theoretically, intraoperative MEP and SEP monitoring can detect neurophysiological changes in the motor cortex/ corticospinal and spinothalamic pathways, respectively, before an actual brain infarction, as inhibition of synaptic transmission occurs before irreversible damage. 14, 17, 19, 23, 44, 46 However, observation and evaluation of sensory function changes is more difficult than observation and evaluation of motor function changes. Thus, clinicians usually focus on MEP monitoring results and consider SEP results as supplemental information that can provide greater coverage of brain lesions with the advantage of continuous monitoring.
False-negative cases in intraoperative transcranial EP monitoring can be explained by different mechanisms. First, direct stimulation of deeper structures within the subcortical motor pathway can bypass the ischemic lesion and lead to false-negative results. 8, 20, 38, 49 Previous studies have reported that even corticospinal axons as deep as the pyramidal decussation can be activated via the foramen magnum at high stimulation intensities. 8, 49 To avoid this phenomenon, some authors suggest direct cortical stimulation via placement of a subdural strip or grid electrode instead of transcranial stimulation. 58, 61, 63 However, direct cortical stimulation also has limitations, such as an increased chance of hemorrhage and brain injury and difficulty in detecting EPs of lower extremities. 38, 61 Furthermore, reports show that transcranial and direct electrical stimulation do not differ in their ability to detect ischemic lesions in the motor pathway. 62 Therefore, our institute prefers transcranial EP monitoring rather than direct cortical stimulation because the conventional pterional approach does not typi- cally expose the motor cortex, and this would force blind insertion of the strip, increasing the chance of brain cortex injury. Additionally, at our institute a preoperative EP evaluation is performed the day before surgery to refine the stimulation intensity and make it as low as possible. Second, motor weakness can occur from a lesion that is not located in the corticospinal pathway. The corticospinal pathway descends through the corona radiata to the internal capsule, cerebral peduncle, basis pontis, and then the medullary pyramids before finally reaching the spinal cord. Infarction in these regions will cause a significant EP change, resulting in hemiplegia. A recent study reported that an ischemic lesion in the premotor area could lead to motor deficits without any significant EP changes. 58 Motor weakness caused by an infarction in the supplemental motor areas and pathways can be hard to distinguish from that caused by pure motor hemiplegia through direct involvement of the motor pathway.
Another possible cause of false-negative results is motor weakness without a neurophysiological change in the axons of the corticospinal pathway. Energy depletion because of the ischemic state causes changes in the EP results. 14, 17, 23 In contrast, an intracranial mass, which causes mechanical compression of the motor pathway due to ICH or subdural hemorrhage (SDH), might result in motor weakness. We could not find evidence of a relationship between mechanical compression and EP changes in human studies. However, in animal studies, it was observed that a large acute SDH could cause a decrease in the amplitude of SEP, whereas a small acute SDH causes only a temporary SEP change. 65 This phenomenon indirectly suggests that a small hemorrhage that does not affect a
FIG. 1.
This 71-year-old woman had a 4-mm aneurysm at the origin of AChA (case 7 in Table 4 ). ICG videoangiography and MVD sonography confirmed the patency of the internal carotid artery and AChA. There was no significant EP change during the operation (A); however, the patient showed grade 4 motor deficits in the right upper and lower extremities. Brain CT scans performed immediately after surgery and 1 day postoperatively revealed nothing abnormal (B), but the patient's motor weakness did not resolve. Thus, diffusion-weighted imaging was performed 3 days postoperatively and revealed a focal acute infarction at the left anteromedial thalamus (C). However, the AChA was shown to be patent by postoperative DSA immediately following the diffusionweighted imaging study (D).
decrease in the cerebral blood flow could result in motor weakness with preserved neurophysiological function. We encountered a false-negative case with postoperative ICH and SAH without any EP change (case 1 in Table 4 ; Fig. 2) .
False-positive transcranial EP monitoring results are usually due to the gap between the brain cortex and the calvaria. Brain shifting caused by excess CSF drainage typically causes this phenomenon. Unfortunately, it is almost impossible to determine whether the positive EP change is true or false, and making a wrong decision could result in a harmful outcome for the patient. Therefore, once there is significant EP change, the surgeon should consider adjusting or repositioning the aneurysm clip. Analyses using additional methods, such as MVD sonography, intraoperative blood flow measurement, and ICG videoangiography, should also be considered. In addition, replacement of CSF with normal saline and slightly rotating the head toward the neutral position can normalize EP results. Despite these methods, there were 15 false-positive cases during the study period. Significant EP changes were considered to be false positives after consolidating results from MVD
FIG. 2.
This 46-year-old woman had a 5.6-mm paraclinoid aneurysm (case 1 in Table 4 ). During the intradural removal of the anterior clinoid process, the surgical high-speed drill injured the medial temporal lobe. The paraclinoid aneurysm was clipped after the bleeding was brought under control. ICG videoangiography and MVD sonography confirmed the patency of the internal carotid artery and its branches, and there were no significant EP changes observed during surgery (A). However, the patient had grade 4 motor deficits in the left upper and lower extremities with ipsilateral ptosis. Postoperative brain CT revealed an ICH in the temporal lobe and an SAH with midline shift toward the contralateral side (B and C).
sonography and ICG videoangiography and comparing them with the anatomical relation of the vasculature to the aneurysm.
As mentioned above, EP changes occur before persistent ischemic brain damage. Thus, persistent and recovered EP changes could have different clinical meanings. MEP and SEP each have different coverage of brain lesions. Thus, the sensitivity, specificity, PPV, and NPV were calculated for each persistent MEP change, persistent SEP change, any MEP change, any SEP change, and overall EP change. We also determined which is the best method to predict ischemic change; however, no significant differences were found by logistic regression analysis. All results tended to show high specificity and NPV with low sensitivity and PPV.
Alert criteria and interpretation of false-positive and false-negative results differ from one study to another. 13,22, 26,37 ,57,58,63,64,68,69 For example, Takebayashi et al. used the complete loss of MEP amplitude as the alert criterion, whereas Szelényi et al. included a case in which the patient experienced delayed motor weakness as a false-negative case. 63, 64 Hence, simple comparison of EP results from each report could lead to misinterpretation. To minimize this issue, we categorized the false-positive and false-negative criteria of previous studies and matched our definitions as closely as possible, depending on the existence of persistent MEP decline and immediate postoperative motor deficits. If there was no description of immediate neurological examinations in other previous studies, operative-day motor weakness was considered an immediate postoperative motor deficit. Thus, despite their different alert criteria, all previous studies resulted in low sensitivity (0.000-0.500) and high specificity (0.990-1.000) with relatively few false-positive (0%-0.99%) and false-negative (0%-40%) cases (Table 6) .
Furthermore, to the best of our knowledge, the current study is the largest survey of EP monitoring to date. Therefore, we had a greater chance of encountering false positives and false negatives. Nonetheless, the incidence of false-positive or false-negative cases was less than 1% in our study. We believe this was the result of 3 key features. First, preoperative EP monitoring provided information about the initial condition of patients for improving the accuracy of our interpretation of EP monitoring results. Second, rigorous EP monitoring techniques ensured highquality EP results. Well-orchestrated total intravenous anesthesia with minimal use of NMB and a carefully refined minimal stimulation intensity (which was lower than in other studies) reduced the chances of a bypass in electrical stimulation (electrical stimulation bypassing the ischemic lesion, which can result in a false negative). Third, communications between the surgeon, anesthesiologist, and neurophysiologist were always open for discussion to gather all opinions and information related to any patient events. These features made EP monitoring an excellent and reliable tool as a surrogate indicator in possible ischemic neurological deficits.
Limitations
Although the present study involved a large group of cases, there were some limitations. Because we used ret-
FIG. 3.
This 72-year-old woman had a 7.4-mm right AChA aneurysm at the point of branching from the right distal internal carotid artery. Two standard clips were applied, leaving enough space from the AChA, which was severely stenotic. However, one of the aneurysm clips had to be placed over a perforating vessel, as the perforator was severely adhered to the aneurysm dome (A). ICG videoangiography confirmed the patent blood flow of AChA (B). However, the EP amplitude dropped more than 50%, but the EP results soon normalized after release of the previously applied aneurysm clips (C). Thus, the aneurysm was partially clipped to preserve the small perforator (D and E). rospective data, we could not unify the use of NMB in an anesthetic regimen, which could potentially alter EP results. 30 Moreover, although we could roughly categorize patients into subgroups, the efficacy of NMB could not be controlled due to multiple variables, such as body weight, operation time, and injection rate. Thus, the use of NMB was only analyzed as additional information for each patient. Second, we could only identify some of the causes of EP changes from EP records, such as temporary clipping of the proximal parent artery or permanent clipping. In addition, some records did not include a description of the event, and there was not an adequate description of how EP results were recovered. Hence, statistical analysis of the cause of EP events was not included.
The time gap between the end of EP monitoring and the start of immediate postoperative neurological examination could also be a limitation. Due to imperfections in the medical records, we could not evaluate the mean time from the end of the monitoring to the immediate postoperative neurological examination. From our experience, it takes 30-60 minutes for patients to wake from anesthesia, and there is a chance of a change in the environment of an intracranial lesion during this period. It is possible that awake surgery could improve or eliminate this issue, but ethical and technical concerns related to this type of surgery would need to be addressed, and this would not be an efficient common surgical protocol. 58 Due to the low incidence of false positives, false negatives, and overall complications, and the size of the population differences between the patient groups, we were unable to demonstrate any statistical significance for independent risk factors associated with false positives, false negatives, or complications. Moreover, the clinically meaningful definition of false positive and false negative differed slightly from those used for statistical analysis. The most challenging part of the current study was defining criteria for false positives and false negatives, as there were various factors to consider, making their definition difficult. Thus, PPV and PNV were calculated for EP results; however, these analyses do not reflect the exact same patient groups as false positives and false negatives. Nevertheless, our study is based on one of the largest reported series of patients who underwent surgical treatment of UIAs with intraoperative EP monitoring, and it included analysis of the incidence of false-positive and false-negative cases.
Finally, there are limitations with transcranial EP monitoring itself. Transcranial EP monitoring can detect neurophysiological changes, but it does not quantify neural damage. Therefore, the finding of a 50% decrease in the amplitude of EP results does not always indicate neurological damage. In our case series, the cerebral infarct lesions in patients with false-negative EP results were focal. These did not result in complete paralysis, and most affected patients recovered within 1 month. Lack of detection by EP monitoring is possible because of partial neural injury or a bypass of stimulation due to a relatively small lesion.
Conclusions
In the present study, intraoperative EP monitoring proved to be an effective tool for detecting impending cerebral ischemia during aneurysm surgery; it had high specificity and NPV. Although the incidence of false-positive and false-negative cases is low, their existence may be a pitfall during aneurysm surgery. However, a meticulously designed protocol helps make EP monitoring an excellent surrogate indicator in cases with a possibility of ischemic neurological deficits.
